{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:55:47Z","timestamp":1790618147449,"version":"4.1.0"},"reference-count":47,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"unspecified","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,9,1]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antidepressant use continues to rise in primary care, often beyond recommended durations. Previous reviews have found insufficient evidence to support long-term antidepressant discontinuation compared with maintenance treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe how antidepressant deprescribing interventions have been designed in primary care and identify features that explore potential reasons for limited effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Scoping review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews (PRISMA-ScR) guidance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>PubMed, Web of Science and PsycINFO were searched through August 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>We included randomised controlled trials and cohort studies of patients prescribed antidepressants despite the absence of current depressive symptoms. Studies were excluded if they were reviews, protocols, case reports, database studies, editorials or commentaries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>Two reviewers independently screened records, with disagreements resolved by a third reviewer. Findings were synthesised descriptively to identify characteristics of study populations, interventions, healthcare professionals and care processes that may help explain the limited effectiveness reported in antidepressant deprescribing trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nine studies were included. RCTs mainly enrolled patients with recurrent depression or major depressive disorder and generally used short tapering schedules. General practitioners led most interventions, while other health care professionals were variably involved. No study reported structured interprofessional collaboration, sustained communication between professionals, or patient and public involvement. Across trials, adherence to deprescribing protocols was moderate to low and relapse rates remained high in most studies. The two cohort studies used longer, more gradual, including hyperbolic, tapering strategies and reported higher discontinuation rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This review identifies population and methodological gaps in antidepressant deprescribing research in primary care. Future studies should include patients with unclear long-term indications or less severe depressive symptoms, use more adaptive tapering strategies and strengthen collaboration between healthcare professionals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-115482","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:00:39Z","timestamp":1790614839000},"page":"e115482","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Why did antidepressant deprescribing fail? A scoping review of contributing factors"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6202-1591","authenticated-orcid":false,"given":"Eiya","family":"Ayed","sequence":"first","affiliation":[{"name":"METRICS ULR 2694, Universite Lille Nord de France, Lille, France"},{"name":"Universite de Lille UFR des Sciences de Sante et du Sport, Lille, Hauts-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7712-4138","authenticated-orcid":false,"given":"Erwin","family":"Gerard","sequence":"additional","affiliation":[{"name":"METRICS ULR 2694, Universite Lille Nord de France, Lille, France"},{"name":"Universite de Lille UFR des Sciences de Sante et du Sport, Lille, Hauts-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0387-2413","authenticated-orcid":false,"given":"Paul","family":"Quindroit","sequence":"additional","affiliation":[{"name":"METRICS ULR 2694, Universite Lille Nord de France, Lille, France"},{"name":"Universite de Lille UFR des Sciences de Sante et du Sport, Lille, Hauts-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1400-4267","authenticated-orcid":false,"given":"Carla","family":"Di Martino","sequence":"additional","affiliation":[{"name":"METRICS ULR 2694, Universite Lille Nord de France, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9546-1808","authenticated-orcid":false,"given":"Antoine","family":"Lamer","sequence":"additional","affiliation":[{"name":"METRICS ULR 2694, Universite Lille Nord de France, Lille, France"},{"name":"Universite de Lille UFR des Sciences de Sante et du Sport, Lille, Hauts-de-France, France"},{"name":"F\u00e9d\u00e9ration R\u00e9gionale de Recherche en Psychiatrie et Sant\u00e9 Mentale Hauts-de-France, Saint-Andr\u00e9-lez-Lille, Nord-Pas-de-Calais-Picardie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Bubrovszky","sequence":"additional","affiliation":[{"name":"F\u00e9d\u00e9ration R\u00e9gionale de Recherche en Psychiatrie et Sant\u00e9 Mentale Hauts-de-France, Saint-Andr\u00e9-lez-Lille, Nord-Pas-de-Calais-Picardie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3005-8147","authenticated-orcid":false,"given":"Jan","family":"Baran","sequence":"additional","affiliation":[{"name":"Universite de Lille UFR des Sciences de Sante et du Sport, Lille, Hauts-de-France, France"},{"name":"Department of General Practice\/Family Medicine, Lille 2 University of Health and Law, LILLE, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4755-5172","authenticated-orcid":false,"given":"Matthieu","family":"Calafiore","sequence":"additional","affiliation":[{"name":"METRICS ULR 2694, Universite Lille Nord de France, Lille, France"},{"name":"Universite de Lille UFR des Sciences de Sante et du Sport, Lille, Hauts-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7752-3964","authenticated-orcid":false,"given":"Annie","family":"Standaert","sequence":"additional","affiliation":[{"name":"Universite de Lille UFR des Sciences de Sante et du Sport, Lille, Hauts-de-France, France"},{"name":"Institute for Translational Research in Inflammation, Lille, Hauts-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0734-8371","authenticated-orcid":false,"given":"Jean-Baptiste","family":"Beuscart","sequence":"additional","affiliation":[{"name":"METRICS ULR 2694, Universite Lille Nord de France, Lille, France"},{"name":"Universite de Lille UFR des Sciences de Sante et du Sport, Lille, Hauts-de-France, France"},{"name":"CERIM EA 2694, University of Lille, Lille, Hauts-de-France, France"},{"name":"Department of Geriatrics, CHRU Lille P\u00f4le Sp\u00e9cialit\u00e9s m\u00e9dicochirurgicales, Lille, Hauts-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"2026092810001886000_16.9.e115482.1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afl023"},{"key":"2026092810001886000_16.9.e115482.2","doi-asserted-by":"publisher","DOI":"10.1177\/0004867415621392"},{"key":"2026092810001886000_16.9.e115482.3","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14475"},{"key":"2026092810001886000_16.9.e115482.4","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320954609","article-title":"Outcome of antidepressant drug discontinuation with taperingstrips after 1-5 years","volume":"10","author":"Groot","year":"2020","journal-title":"Ther Adv Psychopharmacol"},{"key":"2026092810001886000_16.9.e115482.5","unstructured":"Pratt LA , Brody DJ , Gu Q . Antidepressant Use Among Persons Aged 12 and Over:United States,2011-2014. NCHS Data Brief 2017;1\u20138."},{"key":"2026092810001886000_16.9.e115482.6","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-024-03496-8","article-title":"Prolonged increase in psychotropic drug use among young women following the COVID-19 pandemic: a French nationwide retrospective study","volume":"22","author":"Lamer","year":"2024","journal-title":"BMC Med"},{"key":"2026092810001886000_16.9.e115482.7","first-page":"411","article-title":"Antidepressants consumption in the global population in France","volume":"28","author":"Oli\u00e9","year":"2002","journal-title":"Encephale"},{"key":"2026092810001886000_16.9.e115482.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.06.052"},{"key":"2026092810001886000_16.9.e115482.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2006.04.026"},{"key":"2026092810001886000_16.9.e115482.10","doi-asserted-by":"publisher","DOI":"10.3109\/00048674.2010.497477"},{"key":"2026092810001886000_16.9.e115482.11","doi-asserted-by":"publisher","DOI":"10.1159\/000341178"},{"key":"2026092810001886000_16.9.e115482.12","first-page":"95","article-title":"The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) \u2013 New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliability","volume":"53","author":"Cosci","year":"2018","journal-title":"Riv Psichiatr"},{"key":"2026092810001886000_16.9.e115482.13","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1017\/S0033291716002580","article-title":"Predicting relapse after antidepressant withdrawal\u2014A systematic review","volume":"47","author":"Berwian","year":"2017","journal-title":"Psychol Med Feb"},{"key":"2026092810001886000_16.9.e115482.14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jad.2019.03.004","article-title":"Predicting relapse in major depression after successful initial pharmacological treatment","volume":"250","author":"Akechi","year":"2019","journal-title":"J Affect Disord"},{"key":"2026092810001886000_16.9.e115482.15","doi-asserted-by":"crossref","unstructured":"Henssler J , Heinz A , Brandt L , et al . n.d. Antidepressant Withdrawal and Rebound Phenomena. Deutsches \u00c4rzteblatt International PubMed Central PMCID:355\u201361. doi:10.3238\/arztebl.2019.0355","DOI":"10.3238\/arztebl.2019.0355"},{"key":"2026092810001886000_16.9.e115482.16","doi-asserted-by":"crossref","unstructured":"Van Leeuwen E , Mehuys E , Boussery K , et al . Pharmacists\u2019 views on discontinuing long-term use of antidepressants and supporting patients during the discontinuation process: a qualitative study. Br J Gen Pract 2024;74. doi:10.3399\/bjgp24X737781","DOI":"10.3399\/bjgp24X737781"},{"key":"2026092810001886000_16.9.e115482.17","doi-asserted-by":"crossref","unstructured":"Van Leeuwen E , Maund E , Kendrick T , et al . Health professionals\u2019 views on discontinuation of long-term antidepressants: a systematic review and thematic synthesis. Br J Gen Pract 2023;73. doi:10.3399\/bjgp23X733749","DOI":"10.3399\/bjgp23X733749"},{"key":"2026092810001886000_16.9.e115482.18","doi-asserted-by":"crossref","unstructured":"MA Horowitz DT . Books: The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs: An important step, long overdue. Br J Gen Pract 2024;369\u201370. doi:10.3399\/bjgp24X739029","DOI":"10.3399\/bjgp24X739029"},{"key":"2026092810001886000_16.9.e115482.19","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1136\/ebmental-2021-300418","article-title":"Important adverse events to be evaluated in antidepressant trials and meta-analyses in depression: a large international preference study including patients and healthcare professionals","volume":"25","author":"Chevance","year":"2022","journal-title":"Evid Based Ment Health"},{"key":"2026092810001886000_16.9.e115482.20","doi-asserted-by":"crossref","unstructured":"Maund E , Stuart B , Moore M , et al . Managing Antidepressant Discontinuation: A Systematic Review. Ann Fam Med 2019;52\u201360. doi:10.1370\/afm.2336","DOI":"10.1370\/afm.2336"},{"key":"2026092810001886000_16.9.e115482.21","article-title":"Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults","volume":"4","author":"Van Leeuwen","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2026092810001886000_16.9.e115482.22","doi-asserted-by":"crossref","unstructured":"Muskens E , Eveleigh R , Lucassen P , et al . Prescribing ANtiDepressants Appropriately (PANDA): a cluster randomized controlled trial in primary care. BMC Fam Pract 2013;6. doi:10.1186\/1471-2296-14-6","DOI":"10.1186\/1471-2296-14-6"},{"key":"2026092810001886000_16.9.e115482.23","unstructured":"Ayed E , Gerard E , Quindroit P , et al . Antidepressant deprescription: who, how where: protocole. 2024. doi:10.17605\/OSF.IO\/74MQP"},{"key":"2026092810001886000_16.9.e115482.24","doi-asserted-by":"publisher","DOI":"10.1080\/1364557032000119616"},{"key":"2026092810001886000_16.9.e115482.25","doi-asserted-by":"crossref","unstructured":"Levac D , Colquhoun H , O\u2019Brien KK . Scoping studies: advancing the methodology. Implementation Sci 2010;5. doi:10.1186\/1748-5908-5-69","DOI":"10.1186\/1748-5908-5-69"},{"key":"2026092810001886000_16.9.e115482.26","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"2026092810001886000_16.9.e115482.27","doi-asserted-by":"crossref","unstructured":"Batelaan NM , Bosman RC , Muntingh A , et al . Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials. BMJ 2017. doi:10.1136\/bmj.j3927","DOI":"10.1136\/bmj.j3927"},{"key":"2026092810001886000_16.9.e115482.28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-64910-8","article-title":"Antidepressants during and after Menopausal Transition: A Systematic Review and Meta-Analysis","volume":"10","author":"Wu","year":"2020","journal-title":"Sci Rep"},{"key":"2026092810001886000_16.9.e115482.29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2017.11.056","article-title":"Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis","volume":"228","author":"Wagner","year":"2018","journal-title":"J Affect Disord"},{"key":"2026092810001886000_16.9.e115482.30","unstructured":"Covidence . Covidence - better systematic review management. 2025. Available: https:\/\/www.covidence.org\/"},{"key":"2026092810001886000_16.9.e115482.31","unstructured":"Titel: Multidisciplinaire Richtlijn Depressie . Disponible sur. n.d. Available: https:\/\/richtlijnen.nhg.org\/files\/2020-05\/multidisciplinaire_richtlijn_depressie_3e_revisie_2013.pdf"},{"key":"2026092810001886000_16.9.e115482.32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290965","article-title":"Supporting antidepressant discontinuation using mindfulness plus monitoring versus monitoring alone: A cluster randomized trial in general practice","volume":"18","author":"Huijbers","year":"2023","journal-title":"PLoS One"},{"key":"2026092810001886000_16.9.e115482.33","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.115.168971"},{"key":"2026092810001886000_16.9.e115482.34","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1111\/bcp.15805","article-title":"Medication changes implemented during medication reviews and factors related to deprescribing: Posthoc analyses of a randomized clinical trial in geriatric outpatients with polypharmacy","volume":"89","author":"Kornholt","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"2026092810001886000_16.9.e115482.35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.18383","article-title":"Internet and Telephone Support for Discontinuing Long-Term Antidepressants: The REDUCE Cluster Randomized Trial","volume":"7","author":"Kendrick","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026092810001886000_16.9.e115482.36","doi-asserted-by":"crossref","DOI":"10.2196\/25537","article-title":"A Digital Intervention for Primary Care Practitioners to Support Antidepressant Discontinuation (Advisor for Health Professionals): Development Study","volume":"23","author":"Bowers","year":"2021","journal-title":"J Med Internet Res"},{"key":"2026092810001886000_16.9.e115482.37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S2215-0366(18)30100-7","article-title":"Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial","volume":"5","author":"Bockting","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"2026092810001886000_16.9.e115482.38","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(14)62222-4"},{"key":"2026092810001886000_16.9.e115482.39","doi-asserted-by":"publisher","DOI":"10.3310\/hta25590"},{"key":"2026092810001886000_16.9.e115482.40","doi-asserted-by":"crossref","DOI":"10.1186\/1471-244X-11-8","article-title":"Disrupting the rhythm of depression: design and protocol of a randomized controlled trial on preventing relapse using brief cognitive therapy with or without antidepressants","volume":"11","author":"Bockting","year":"2011","journal-title":"BMC Psychiatry"},{"key":"2026092810001886000_16.9.e115482.41","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11121633","article-title":"Biological, Psychological, and Social Determinants of Depression: A Review of Recent Literature","volume":"11","author":"Remes","year":"2021","journal-title":"Brain Sci"},{"key":"2026092810001886000_16.9.e115482.42","first-page":"246","article-title":"Artificial Intelligence in Pharmaceutical Care Management for Anxiety, Depression, and Schizophrenia: A Narrative Review","volume":"4","author":"Jamil","year":"2025","journal-title":"Pak J Med Cardiol Rev"},{"key":"2026092810001886000_16.9.e115482.43","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.sapharm.2025.06.107","article-title":"An assessment of generative artificial intelligence in responding to clinical queries on tapering antidepressants","volume":"21","author":"Mac Oscar","year":"2025","journal-title":"Research in Social and Administrative Pharmacy"},{"key":"2026092810001886000_16.9.e115482.44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/bcp.16191","article-title":"Mobile applications on app stores for deprescribing: A scoping review","volume":"91","author":"Okati","year":"2025","journal-title":"Brit J Clinical Pharma"},{"key":"2026092810001886000_16.9.e115482.45","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-018-1007-9","article-title":"International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy","volume":"16","author":"Beuscart","year":"2018","journal-title":"BMC Med"},{"key":"2026092810001886000_16.9.e115482.46","doi-asserted-by":"crossref","unstructured":"Clarke M . Standardising outcomes for clinical trials and systematic reviews. Trials 2007;8. doi:10.1186\/1745-6215-8-39","DOI":"10.1186\/1745-6215-8-39"},{"key":"2026092810001886000_16.9.e115482.47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jclinepi.2014.09.022","article-title":"Survey of new 2007 and 2011 Cochrane reviews found 37% of prespecified outcomes not reported","volume":"68","author":"Smith","year":"2015","journal-title":"J Clin Epidemiol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-115482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:00:46Z","timestamp":1790614846000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-115482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,28]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bmjopen-2025-115482"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-115482","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}